Rim2 Activators
Rim2 Activators encompass a diverse array of chemical compounds that indirectly enhance Rim2's functional activity, primarily in synaptic vesicle exocytosis and neurotransmitter release. Forskolin, Epigallocatechin gallate (EGCG), IBMX, Rolipram, Cilostazol, Vinpocetine, and Isoproterenol operate through elevating cAMP levels in neurons, subsequently activating the PKA signaling pathway. This pathway is crucial for the phosphorylation of proteins involved in neurotransmitter release, a key process where Rim2 plays an integral role. For instance, Forskolin, by increasing cAMP, indirectly facilitates Rim2's involvement in synaptic vesicle priming, while Rolipram specifically heightens Rim2's functionality by inhibiting PDE4, thus raising cAMP levels. These compounds, through their targeted actions, enhance Rim2's role in modulating synaptic vesicle dynamics, which is pivotal for efficient neurotransmitter release.
Additionally, compounds like Zaprinast, Sildenafil, Vardenafil, and Tadalafil, which are primarily PDE5 inhibitors, augment cGMP levels in neurons. The increased cGMP indirectly enhances Rim2's activity in synaptic vesicle exocytosis by influencing pathways associated with cGMP signaling. For example, Sildenafil's inhibition of PDE5 results in elevated cGMP, which indirectly potentiates Rim2's function in the synaptic vesicle cycle. Furthermore, Yohimbine, an alpha-2 adrenergic receptor antagonist, indirectly augments Rim2's role by increasing neurotransmitter release, thereby enhancing the neuronal firing rate, a process in which Rim2 is inherently involved. Collectively, these activators work through distinct but converging pathways to indirectly enhance Rim2's functional activity in synaptic vesicle exocytosis, highlighting their critical role in modulating neuronal communication.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin enhances intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can impact neurotransmitter release, a process in which Rim2 plays a crucial role by regulating synaptic vesicle exocytosis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits phosphodiesterases, leading to increased cAMP levels. This elevation indirectly enhances Rim2's function in synaptic vesicle priming and exocytosis by modulating the cAMP/PKA signaling pathway. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, increasing cAMP and cGMP levels in neurons. This rise in cAMP indirectly augments Rim2's role in synaptic vesicle exocytosis. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective PDE4 inhibitor, increases cAMP levels in neurons. Elevated cAMP indirectly enhances Rim2's function in neurotransmitter release by modulating the cAMP/PKA signaling pathway. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast increases cGMP levels by inhibiting PDE5. Elevated cGMP can enhance Rim2's function indirectly by modulating signaling pathways that influence synaptic vesicle exocytosis. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol inhibits PDE3, leading to increased cAMP levels. The elevated cAMP indirectly enhances Rim2's function in neurotransmitter release by influencing the cAMP/PKA signaling pathway. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine inhibits PDE1, increasing cAMP and cGMP levels. This enhancement of cAMP and cGMP levels can indirectly influence Rim2's role in synaptic vesicle priming and neurotransmitter release. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels in neurons. Elevated cAMP indirectly augments Rim2's function in synaptic vesicle exocytosis via the cAMP/PKA signaling pathway. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a PDE5 inhibitor, increases cGMP levels. This elevation indirectly enhances Rim2's function in synaptic vesicle exocytosis by modulating signaling pathways influenced by cGMP. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine, an alpha-2 adrenergic receptor antagonist, can increase neurotransmitter release. This indirectly augments Rim2’s role in synaptic vesicle exocytosis by increasing the neuronal firing rate and neurotransmitter release. | ||||||